Karen Colwill
Overview
Explore the profile of Karen Colwill including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
3437
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Walmsley S, Nabipoor M, Lovblom L, Ravindran R, Colwill K, Mcgeer A, et al.
Vaccines (Basel)
. 2024 Jan;
12(1).
PMID: 38250849
The initial two-dose vaccine series and subsequent booster vaccine doses have been effective in modulating SARS-CoV-2 disease severity and death but do not completely prevent infection. The correlates of infection...
12.
Di Meo A, Ma L, Yau K, Abe K, Colwill K, Gingras A, et al.
Clin Biochem
. 2023 Nov;
121-122:110681.
PMID: 37913837
Background: Hemodialysis patients exhibit variable immunogenicity following administration of the SARS-CoV-2 mRNA vaccine. The aim of the current study was to evaluate the use of two commercial assays in the...
13.
Camirand Lemyre F, Hermann Honfo S, Caya C, Cheng M, Colwill K, Corsini R, et al.
Vox Sang
. 2023 Oct;
118(12):1069-1077.
PMID: 37850270
Background And Objectives: In this proof-of-concept study, which included blood donor samples, we aimed to demonstrate how Bayesian latent class models (BLCMs) could be used to estimate SARS-CoV-2 seroprevalence in...
14.
Yau K, Tam P, Chan C, Hu Q, Qi F, Abe K, et al.
Clin J Am Soc Nephrol
. 2023 Oct;
19(1):85-97.
PMID: 37847518
Background: There is a lack of randomized controlled trial data regarding differences in immunogenicity of varying coronavirus disease 2019 (COVID-19) mRNA vaccine regimens in CKD populations. Methods: We conducted a...
15.
Matveev V, Mihelic E, Benko E, Budylowski P, Grocott S, Lee T, et al.
iScience
. 2023 Oct;
26(10):107915.
PMID: 37790281
Older individuals and people with HIV (PWH) were prioritized for COVID-19 vaccination, yet comprehensive studies of the immunogenicity of these vaccines and their effects on HIV reservoirs are not available....
16.
Yau K, Kurtesi A, Qi F, Delgado-Brand M, Tursun T, Hu Q, et al.
Nat Commun
. 2023 Sep;
14(1):6041.
PMID: 37758707
Neutralization of Omicron subvariants by different bivalent vaccines has not been well evaluated. This study characterizes neutralization against Omicron subvariants in 98 individuals on dialysis or with a kidney transplant...
17.
Murphy T, Swail H, Jain J, Anderson M, Awadalla P, Behl L, et al.
CMAJ
. 2023 Aug;
195(31):E1030-E1037.
PMID: 37580072
Background: During the first year of the COVID-19 pandemic, the proportion of reported cases of COVID-19 among Canadians was under 6%. Although high vaccine coverage was achieved in Canada by...
18.
Matveev V, Mihelic E, Benko E, Budylowski P, Grocott S, Lee T, et al.
bioRxiv
. 2023 Jul;
PMID: 37502977
Older individuals and people with HIV (PWH) were prioritized for COVID-19 vaccination, yet comprehensive studies of the immunogenicity of these vaccines and their effects on HIV reservoirs are not available....
19.
Lin Y, Evans D, Robbins N, Orjuela G, Abe K, Rathod B, et al.
Microbiol Spectr
. 2023 Jun;
11(4):e0525622.
PMID: 37289096
The 50% plaque reduction neutralization assay (PRNT) has been previously used to assess the neutralization capacity of donor plasma against wild-type and variant of concern (VOC) severe acute respiratory syndrome...
20.
Walmsley S, Szadkowski L, Wouters B, Clarke R, Colwill K, Rochon P, et al.
iScience
. 2023 Apr;
26(4):106506.
PMID: 37073374
We report a decentralized prospective cohort study of self-reported adverse events and antibody responses to COVID vaccines derived from dried blood spots. Data are presented for 911 older (aged >70...